- On Announcement of All Oral MDR TB regimen by Indian Government
- Modi visit to US: Trump appearance signals importance of India
- After ‘Howdy Modi’, Trump and Modi likely to sign trade deal
- US – India Relations: President Trump To Sign New Trade Deal With Indian PM Modi?
- India-US trade talks: Trading lives?
Category Archives: Public research
by Jason Cone, The Hill The White House Council of Economic Advisers recently announced a strategy to curb high drug prices: force “free riding” countries abroad to pay more and watch the prices go down in America. That’s not how … Continue reading
Bloomberg View; March 23, 2016. By Noah Smith. One of the biggest stories in science right now is the fight over the Crispr patents. Crispr is a gene editing technique that promises to allow previously unthinkable feats of bio-engineering. It was … Continue reading
IP Watch; December 8, 2015. A newly issued report provides the “first ever” picture of global investment in Ebola research and development. The report found that investment in Ebola might have come at the expense of other funding to develop drugs, … Continue reading
The Medicines Patent Pool Signs a Collaborative Agreement with the University of Liverpool to Develop HIV Nanomedicines
Medicines Patent Pool; December 1, 2015. Geneva – The Medicines Patent Pool (MPP) today announced a collaboration with the University of Liverpool and a licence for the university’s Solid Drug Nanoparticle (SDN) technology to accelerate the development of WHO-recommended antiretrovirals as nanomedicines. The … Continue reading
Providence Journal, November 3, 2015. By Mariana Mazzucato. When Martin Shkreli of Turing Pharmaceuticals raised the price for Daraprim by 5,455 percent, he put drug pricing on the agenda for the leading 2016 presidential candidates. Bernie Sanders is reported to have … Continue reading